Mehren Lawrence 4
4 · Accelerate Diagnostics, Inc · Filed Jan 3, 2019
Insider Transaction Report
Form 4
Mehren Lawrence
DirectorCEO10% Owner
Transactions
- Award
Employee Stock Option (right to buy)
2019-01-01+209,930→ 209,930 totalExercise: $11.50Exp: 2029-01-01→ Common Stock (209,930 underlying) - Award
Employee Stock Option (right to buy)
2019-01-01$3.31/sh+37,736$124,906→ 37,736 totalExercise: $11.50Exp: 2029-01-01→ Common Stock (37,736 underlying)
Footnotes (3)
- [F1]The options vest in four (4) equal annual installments on each anniversary of the date of grant beginning on January 1, 2021.
- [F2]The options vest in twelve (12) equal monthly installments beginning on January 31, 2019.
- [F3]The options were issued to the reporting person under the 2019 Salary Waiver and Nonqualified Stock Option Grant Plan (the "Sub-Plan") established pursuant to the Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan. Pursuant to the terms of the Sub-Plan, the reporting person irrevocably waived $125,000 of base compensation scheduled to be paid to the reporting person in 2019 in exchange for such options.